|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 39.31 USD | -1.70% |
|
+5.70% | +58.41% |
| 10-16 | William Blar Initiates Coverage on Edgewise Therapeutics With Outperform Rating | MT |
| 10-08 | Edgewise Therapeutics Doses First Patient in Trial of Investigational Heart Failure Drug | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| EWTX | Delayed | |
CBOE
| EWTX | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 41.4 | 48.35 | 45.41 |
| Spread/Res. | -5.05% | -18.70% | -13.43% |
| Spread/Supp. | +8.35% | +29.10% | +20.21% |
| Support | 36.28 | 30.45 | 32.7 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- EWTX Stock
- Charts Edgewise Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
